THYROID GLAND ANAPLASTIC CARCINOMA
Clinical trials for THYROID GLAND ANAPLASTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND ANAPLASTIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND ANAPLASTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radioactive drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, [177Lu]Lu-AKIR001, in 15 adults with advanced solid tumors (like thyroid, head and neck, cervical, vulvar, or lung cancer) that have stopped responding to standard treatments. The main goal is to check the drug's safety and sid…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated May 17, 2026 01:47 UTC
-
New combo therapy targets deadly thyroid cancer in early trial
Disease control Recruiting nowThis early-phase study tests whether adding two targeted drugs (dabrafenib and trametinib) to standard radiation therapy can better control anaplastic thyroid cancer that has a specific BRAF mutation. The trial enrolls about 6 people with this rare and aggressive cancer. The main…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC